Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bartsch

Showing results (61-70 of 228) with videos related to

Pageof 23
Sort By:
Cancer Treatment Reviews|December 20, 2023
Pharmacotherapy for leptomeningeal disease in breast cancerRupert Bartsch, Katarzyna J Jerzak, Louis Larrouquere, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma modelMaria I Körber, Simone Klingenbrunner, Rupert Bartsch, et al.
BMC Cancer|August 26, 2011
Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trialMichael Fiegl, Brigitte Mlineritsch, Michael Hubalek, et al.
Breast Cancer Research and Treatment|December 18, 2012
Trastuzumab administration during pregnancy: a systematic review and meta-analysisFlora Zagouri, Theodoros N Sergentanis, Dimosthenis Chrysikos, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 2013
Exosomal microRNA transfer varies with specific microRNAs functional in colorectal cancer and cellular differentiationMarlies I Moshammer, Maria Kalipciyan, Rupert Bartsch, et al.
Cancer Treatment Reviews|March 9, 2023
Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature reviewVolkmar Müller, Rupert Bartsch, Nancy U Lin, et al.
Oncology and Therapy|November 8, 2025
Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative ReviewMarina E Cazzaniga, Luis Costa, Gilles Freyer, et al.
Wiener Klinische Wochenschrift|September 8, 2023
Updated Austrian treatment algorithm for metastatic triple-negative breast cancerRupert Bartsch, Gabriel Rinnerthaler, Edgar Petru, et al.
Wiener Klinische Wochenschrift|February 24, 2010
Attitudes towards palliative care in primary metastatic cancer: a survey among oncologistsKatharina A Kierner, Verena Gartner, Rupert Bartsch, et al.
Cancer Treatment Reviews|June 30, 2020
Intrathecal administration of anti-HER2 treatment for the treatment of meningeal carcinomatosis in breast cancer: A metanalysis with meta-regressionFlora Zagouri, Panagiotis Zoumpourlis, Emilie Le Rhun, et al.
Pageof 23

Showing results (61-70 of 228) with videos related to

Sort By:
Pageof 23
Cancer Treatment Reviews|December 20, 2023
Pharmacotherapy for leptomeningeal disease in breast cancerRupert Bartsch, Katarzyna J Jerzak, Louis Larrouquere, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma modelMaria I Körber, Simone Klingenbrunner, Rupert Bartsch, et al.
BMC Cancer|August 26, 2011
Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trialMichael Fiegl, Brigitte Mlineritsch, Michael Hubalek, et al.
Breast Cancer Research and Treatment|December 18, 2012
Trastuzumab administration during pregnancy: a systematic review and meta-analysisFlora Zagouri, Theodoros N Sergentanis, Dimosthenis Chrysikos, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 2013
Exosomal microRNA transfer varies with specific microRNAs functional in colorectal cancer and cellular differentiationMarlies I Moshammer, Maria Kalipciyan, Rupert Bartsch, et al.
Cancer Treatment Reviews|March 9, 2023
Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature reviewVolkmar Müller, Rupert Bartsch, Nancy U Lin, et al.
Oncology and Therapy|November 8, 2025
Risk Factors for Disease Recurrence in Patients with HER2+ Early Breast Cancer and Implications for Therapy: A Narrative ReviewMarina E Cazzaniga, Luis Costa, Gilles Freyer, et al.
Wiener Klinische Wochenschrift|September 8, 2023
Updated Austrian treatment algorithm for metastatic triple-negative breast cancerRupert Bartsch, Gabriel Rinnerthaler, Edgar Petru, et al.
Wiener Klinische Wochenschrift|February 24, 2010
Attitudes towards palliative care in primary metastatic cancer: a survey among oncologistsKatharina A Kierner, Verena Gartner, Rupert Bartsch, et al.
Cancer Treatment Reviews|June 30, 2020
Intrathecal administration of anti-HER2 treatment for the treatment of meningeal carcinomatosis in breast cancer: A metanalysis with meta-regressionFlora Zagouri, Panagiotis Zoumpourlis, Emilie Le Rhun, et al.
Pageof 23